News & Articles

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions

Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology

Learn how a generics pharmaceutical company in the U.S. is simplifying chromatography data management for greater productivity

CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic

The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay

The Proxima spatial analysis software solution integrates image acquisition to data analysis in the secure cloud for rapid access by any user

cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus

Join Waters on Wednesday, October 7, for a panel discussion and insights from the USP and MHRA

AstraZeneca anticipates entering clinical development in 2021

The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus

The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity

New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs

New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19

New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus

Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021

Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method

Rapid increase in production of VTM and saline will help boost virus testing

A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients

The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses